company background image
4105 logo

TTY Biopharm TPEX:4105 Stock Report

Last Price

NT$75.90

Market Cap

NT$18.9b

7D

-1.9%

1Y

-0.4%

Updated

13 Jun, 2024

Data

Company Financials +

TTY Biopharm Company Limited

TPEX:4105 Stock Report

Market Cap: NT$18.9b

4105 Stock Overview

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

4105 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends5/6

TTY Biopharm Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for TTY Biopharm
Historical stock prices
Current Share PriceNT$75.90
52 Week HighNT$87.00
52 Week LowNT$74.80
Beta0.23
1 Month Change-2.44%
3 Month Change-7.21%
1 Year Change-0.39%
3 Year Change-10.07%
5 Year Change-7.55%
Change since IPO1,154.39%

Recent News & Updates

Recent updates

Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

Apr 02
Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

Is There An Opportunity With TTY Biopharm Company Limited's (GTSM:4105) 43% Undervaluation?

Mar 15
Is There An Opportunity With TTY Biopharm Company Limited's (GTSM:4105) 43% Undervaluation?

Are Dividend Investors Making A Mistake With TTY Biopharm Company Limited (GTSM:4105)?

Feb 25
Are Dividend Investors Making A Mistake With TTY Biopharm Company Limited (GTSM:4105)?

TTY Biopharm Company Limited (GTSM:4105) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Feb 07
TTY Biopharm Company Limited (GTSM:4105) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

TTY Biopharm Company Limited (GTSM:4105) Analysts Just Cut Their EPS Forecasts Substantially

Jan 19
TTY Biopharm Company Limited (GTSM:4105) Analysts Just Cut Their EPS Forecasts Substantially

What Type Of Returns Would TTY Biopharm's(GTSM:4105) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Jan 10
What Type Of Returns Would TTY Biopharm's(GTSM:4105) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

Dec 15
TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

How Does TTY Biopharm Company Limited (GTSM:4105) Fare As A Dividend Stock?

Nov 25
How Does TTY Biopharm Company Limited (GTSM:4105) Fare As A Dividend Stock?

Shareholder Returns

4105TW PharmaceuticalsTW Market
7D-1.9%0.1%2.5%
1Y-0.4%6.5%26.3%

Return vs Industry: 4105 underperformed the TW Pharmaceuticals industry which returned 5.8% over the past year.

Return vs Market: 4105 underperformed the TW Market which returned 25.3% over the past year.

Price Volatility

Is 4105's price volatile compared to industry and market?
4105 volatility
4105 Average Weekly Movement1.8%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4105 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4105's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1960n/an/awww.tty.com.tw

TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments.

TTY Biopharm Company Limited Fundamentals Summary

How do TTY Biopharm's earnings and revenue compare to its market cap?
4105 fundamental statistics
Market capNT$18.87b
Earnings (TTM)NT$1.17b
Revenue (TTM)NT$5.61b

16.1x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4105 income statement (TTM)
RevenueNT$5.61b
Cost of RevenueNT$2.26b
Gross ProfitNT$3.35b
Other ExpensesNT$2.18b
EarningsNT$1.17b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.71
Gross Margin59.68%
Net Profit Margin20.86%
Debt/Equity Ratio27.0%

How did 4105 perform over the long term?

See historical performance and comparison

Dividends

4.6%

Current Dividend Yield

74%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.